SC
Suryabhan Chauhan
About Suryabhan Chauhan
Suryabhan Chauhan has 11 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Tamsa Biotech Multiservices Private Limited and Ansh India Mutual Benefit Nidhi Limited. Formerly with 1 company. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Tamsa Biotech Multiservices Private Limited
U51909UP2020PTC129082
|
Director | 04 Jun 2020 | 2020 | Active |
Ansh India Mutual Benefit Nidhi Limited
U65990UP2019PLC113996
|
Director | 23 May 2019 | 2019 | Active |
Reliant Multiservices Private Limited
U74999UP2019PTC120497
|
Director | 23 Aug 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Angelindia Mutual Benefit Limited
U65991UP2013PLC061454
|
Additional Director | 28 Oct 2014 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suryabhan Chauhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suryabhan Chauhan
Suryabhan Chauhan has 11 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Tamsa Biotech Multiservices Private Limited and Ansh India Mutual Benefit Nidhi Limited. Formerly with 1 company. Engaged in Technology, General Business. Contributes to corporate operations.
Suryabhan Chauhan is associated with 3 companies as Director and Additional Director.
Suryabhan Chauhan has expertise in Technology, General Business.
Suryabhan Chauhan has 11 years in corporate governance.